420 related articles for article (PubMed ID: 17716785)
1. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
2. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2006 Sep; 51(4):885-95. PubMed ID: 16901518
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
[TBL] [Abstract][Full Text] [Related]
4. Free radical production induced by methamphetamine in rat striatal synaptosomes.
Pubill D; Chipana C; Camins A; Pallàs M; Camarasa J; Escubedo E
Toxicol Appl Pharmacol; 2005 Apr; 204(1):57-68. PubMed ID: 15781294
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.
Garcia-Ratés S; Camarasa J; Escubedo E; Pubill D
Toxicol Appl Pharmacol; 2007 Sep; 223(3):195-205. PubMed ID: 17614110
[TBL] [Abstract][Full Text] [Related]
6. The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation.
Garcia-Ratés S; Camarasa J; Sánchez-García AI; Gandía L; Escubedo E; Pubill D
Toxicol Appl Pharmacol; 2010 May; 244(3):344-53. PubMed ID: 20132834
[TBL] [Abstract][Full Text] [Related]
7. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex.
Drew AE; Derbez AE; Werling LL
Synapse; 2000 Oct; 38(1):10-6. PubMed ID: 10941136
[TBL] [Abstract][Full Text] [Related]
9. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
10. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
Chipana C; Torres I; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2008 Jun; 54(8):1254-63. PubMed ID: 18455739
[TBL] [Abstract][Full Text] [Related]
11. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Sidhpura N; Redfern P; Wonnacott S
Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
[TBL] [Abstract][Full Text] [Related]
13. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
14. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
16. Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells.
Montiel-Duarte C; Ansorena E; López-Zabalza MJ; Cenarruzabeitia E; Iraburu MJ
Biochem Pharmacol; 2004 Mar; 67(6):1025-33. PubMed ID: 15006539
[TBL] [Abstract][Full Text] [Related]
17. Memantine prevents MDMA-induced neurotoxicity.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neurotoxicology; 2008 Jan; 29(1):179-83. PubMed ID: 17980434
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
Nair SG; Gudelsky GA
Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
[TBL] [Abstract][Full Text] [Related]
19. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
Dwoskin LP; Teng L; Buxton ST; Crooks PA
J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
Giambalvo CT
Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
